Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Carrying LegitScript verification means a platform has met compliance standards for legitimate online healthcare operations - including prescription drug practices, licensing, and operational transparency
Known side effects (class effects similar to other GLP-1 medications) Gastrointestinal issues (very common): Nausea: 38-43% of participants vs 11% placebo Diarrhea: 33-35% vs 13% placebo Vomiting: 20-21% vs 0% placebo Constipation: 22-25% vs 9% placebo Decreased appetite: 18-19% vs 9% placebo These are expected with incretin-based therapies and typically improve over time as your body adjusts
Aqu te ofrecemos una variedad de productos que ayudan a incrementar tu bienestar de manera efectiva y segura
Both are established options in the GLP-1 drug class: tirzepatide is a dual GLP-1/GIP agonist, while semaglutide is a GLP-1 receptor agonist
US$ 22.36
US$ 26.70
US$ 29.34
US$ 21.12
